RPS3 and melanoma: Interaction of total RPS3 with HNRNPU showed a decrease in the cytoplasmic fraction of NRAS mutant melanoma cells treated with MEKi and in BRAF mutant cells treated with combination mBRAFi/MEKi as assessed by PLA analysis.